Connect with us

Public Companies

News You Might Have Missed – September 7, 2021

The article News You Might Have Missed – September 7, 2021 was originally published on Microdose.

Welcome to the News You Might Have Missed, a weekly…

Published

on

The article News You Might Have Missed – September 7, 2021 was originally published on Microdose.   Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed. It was a busy week with lots of news, have a look and see you next week for another update. Filament Health Files 20th Patent Application Including Three International PCT Applications The company announced that it has filed its 20th patent application in support of the Company’s research phase programs. These filings include three international Patent Cooperation Treaty (PCT) patent applications. Read more MINDCURE Announces Financial Results for Fiscal 2021 The company announced its financial results for the three and twelve months ended May 31, 2021. Read more Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada The company announced that it has completed another export of the Company’s freshly harvested high-grade psilocybe truffles in bulk quantity, from the Netherlands to Canada, under a Health Canada psilocybin import permit. Read more PsyBio Therapeutics Reports Second Quarter 2021 Financial Results The company announced its financial results and business highlights for Q2 2021. Read more MindMed and BioXcel Therapeutics Publish an International Patent Application The disclosure provides a method for measuring the signs of an impending agitation event and alerts the caregiver to treat the subject before agitation symptoms arise. Read more Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers. Read more Cybin Announces Additional Adelia Milestone Achievements Cybin is pleased to announce that Adelia Therapeutics Inc. (“Adelia”), a wholly-controlled subsidiary of Cybin, has achieved certain milestones for Year 1 Q3. Read more Mindset Pharma Announces its Novel 5-MeO-DMT Psychedelic Analogs Demonstrate a Significantly Improved Safety Profile in Preclinical Results Mindset’s next generation 5-MeO-DMT drug candidates have shown a significant decrease in serotonergic toxicity; results reaffirm superior efficacy and safety. Read more

Read More

Trending